WP-RTCG
From $168.99 / vial
For in-vitro laboratory research use only. Not for human or veterinary use.
Reference compound: Retatrutide / Cagrilintide blend · CAS 2381089-83-2 / 1415456-99-3. Lyophilized powder, 10 mg (5 mg / 5 mg). Single vial, Buy-2-Get-1 3-pack, or 10-vial lab kit. For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
What WP-RTCG is
This research blend supplies retatrutide and cagrilintide in equal mass in a single lyophilized vial for laboratories studying incretin–amylin co-agonism. Retatrutide is a GIP/GLP-1/glucagon receptor tri-agonist; cagrilintide is a long-acting amylin analog acting at calcitonin-receptor/RAMP complexes.
Mechanism described in the literature
The combination of a GLP-1-class agonist with an amylin analog is studied because the two act on largely separate receptor systems and brain regions (hypothalamic and hindbrain incretin pathways versus area-postrema amylin signaling). The published co-agonism literature concerns semaglutide plus cagrilintide (CagriSema); no clinical program exists for retatrutide combined with cagrilintide, and this blend is supplied for exploratory in-vitro work only.
Research areas
- Incretin–amylin receptor co-agonism
- Additive and synergistic signaling in cell models
- Comparative pharmacology against single agents
Specifications
| Product code | WP-RTCG |
|---|---|
| Reference compound | Retatrutide / Cagrilintide blend |
| CAS number | 2381089-83-2 / 1415456-99-3 |
| Molecular formula | Blend |
| Molecular weight | Blend |
| Composition | Two-peptide blend: 5 mg retatrutide + 5 mg cagrilintide per 10 mg vial; acetate salts |
| Form | Lyophilized powder |
| Net content options | 10 mg (5 mg / 5 mg) |
| Container | 3 mL clear glass vial, crimped aluminum seal, flip-off cap |
| Storage | Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake. |
| Intended use | In-vitro laboratory research only |
Sizes and packs
Single vial at list price · 3-Pack = Buy 2, Get 1 Free (exactly 2× list) · 10-Vial Lab Kit = 25% off list. Select the size and pack above; the price updates.
Handling and storage
Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake.
Vials ship sealed, cushioned and with a desiccant pack in plain packaging. Each vial is labeled with the product code, net content and the research-use designation. A packing slip lists the product codes and quantities ordered.
Frequently asked questions
Who can order?
Qualified researchers aged 21+ purchasing for in-vitro laboratory research. You confirm this at site entry and again at checkout.
When does it ship?
Orders confirmed by 2 PM CT ship the same business day by USPS Priority Mail (1–3 business days). Free shipping on orders over $149. Tracking is emailed when the carrier scans the label.
Can I return it?
All sales are final. Items that arrive damaged or incorrect are replaced when reported with photos within 72 hours of delivery — see Shipping & Returns.
References
- Coskun T, Urva S, Roell WC, et al.. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metabolism 2022. doi:10.1016/j.cmet.2022.07.013
- Kruse T, Hansen JL, Dahl K, et al.. Development of Cagrilintide, a Long-Acting Amylin Analogue. Journal of Medicinal Chemistry 2021. doi:10.1021/acs.jmedchem.1c00565
- Enebo LB, Berthelsen KK, Kankam M, et al.. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. The Lancet 2021. doi:10.1016/S0140-6736(21)00845-X
This overview summarizes published literature about the reference compound and is provided for research context only. It is not a description of the properties, effects or uses of this product, which is supplied strictly for in-vitro laboratory research by qualified researchers. Nothing on this page is an instruction for preparation or use.
For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.
Available sizes and packs
| Weight | N/A |
|---|---|
| Size | 10 mg (5 mg / 5 mg) |
| Pack | Single vial, 3-Pack · Buy 2 Get 1 Free, 10-Vial Lab Kit |







